Skip to main content

Diarrhea, Acute News

Related terms: Diarrhea, drug-induced

Cucumbers Sold in 14 States Recalled Over Salmonella Concerns

TUESDAY, June 4, 2024 – A company recall has been issued for cucumbers sold in 14 states because of possible contamination with salmonella. In a notice posted by the U.S. Food and Drug...

E. Coli Outbreak Tied to Raw Milk Cheese

MONDAY, Feb. 19, 2024 – Raw milk cheese tainted with E. coli bacteria has sickened 10 people in four states, hospitalizing four, federal regulators warn. The cases have been tied to Raw Farm brand...

CDC Investigating Illness Outbreak on Luxury Cruise Ship

Thursday, Feb. 8, 2024 – The U.S. Centers of Disease Control and Prevention is investigating an outbreak of gastrointestinal illness aboard a luxury cruise ship that sailed out of San Francisco on...

Climate Change Could Make Diarrheal Illness More Common

FRIDAY, Jan. 19, 2024 – People are more prone to coming down with a common gastrointestinal infection on hot, humid days, new research shows. The British study suggests that climate change and...

What's in the Water? Maybe Germs That Could Harm You

TUESDAY, July 4, 2023 – Under the surface of your favorite swimming pool, beach and lakes, hazards too small to be seen by the naked eye may await. And these bacteria, viruses and parasites can turn...

FDA Medwatch Alert: Drug Safety Communication: Imodium (loperamide) for Over-the-Counter Use - FDA Limits Packaging To Encourage Safe Use

ISSUE: To foster safe use of the over-the counter (OTC) anti-diarrhea drug loperamide, FDA is working with manufacturers to use blister packs or other single dose packaging and to limit the number of...

FDA Medwatch Alert: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall - Possible Sub Potent and Super Potent Tablets

ISSUE: Greenstone, a wholly owned subsidiary of Pfizer Inc., is voluntarily recalling multiple lots of diphenoxylate hydrochloride and atropine sulfate tablets, USP to the consumer level. Greenstone...

FDA Approves Fulyzaq - First Anti-Diarrheal Drug for HIV/AIDS Patients

December 31, 2012 – The U.S. Food and Drug Administration today approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Diarrhea

Related drug support groups

Pepto-Bismol, Imodium